Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
cnbc.com
/
Share Newsitem
View, share or embed this newsitem using the details below.
CNBC - Business and Financial Market News
@cnbc.com
/
2 days
2d
Follow
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
https://newsreadery.com/go/25c19dd3fd19eebfb89be329f35b6439
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-25c19dd3fd19eebfb89be329f35b6439"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2F25c19dd3fd19eebfb89be329f35b6439" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...
